Scilex Holding Change in Accounts Payable 2021-2025 | SCLX

Scilex Holding change in accounts payable from 2021 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.

Scilex Holding Change in Accounts Payable 2021-2025 | SCLX

Scilex Holding change in accounts payable from 2021 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$245.5B
Amgen (AMGN)$159.6B
Gilead Sciences (GILD)$146.9B
Vertex Pharmaceuticals (VRTX)$100.7B
Bristol Myers Squibb (BMY)$98.6B
CSL (CSLLY)$85.1B
GSK (GSK)$80.2B
Regeneron Pharmaceuticals (REGN)$61.5B
Alnylam Pharmaceuticals (ALNY)$58.8B
Argenex SE (ARGX)$40B
BioNTech SE (BNTX)$27.3B
Insmed (INSM)$27B
Royalty Pharma (RPRX)$21.2B
Biogen (BIIB)$20.3B
Incyte (INCY)$17B
Illumina (ILMN)$15.4B
Genmab (GNMSF)$15.3B
Genmab (GMAB)$15B
Ascendis Pharma (ASND)$12.1B
BioMarin Pharmaceutical (BMRN)$11B
QIAGEN (QGEN)$11B
Moderna (MRNA)$10.9B
Swedish Orphan Biovitrum (BIOVF)$10.3B
Exelixis (EXEL)$10.3B
Verona Pharma American Depositary Share (VRNA)$9B
Exact Sciences (EXAS)$8.6B
Bio-Techne Corp (TECH)$8.4B
Blueprint Medicines (BPMC)$8.3B
Roivant Sciences (ROIV)$8.1B
Halozyme Therapeutics (HALO)$7.9B